close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar96Point46
Implied share price

Buy Undervalued by 11.7%

5% margin of safety What's this?

EV / EBITDA
Use Average
JNJ
Johnson & Johnson
PFE
Pfizer Inc.
Change
NVS
Novartis AG (ADR)
Change
MRK
Merck & Co., Inc.
Change
GSK
GlaxoSmithKline plc (ADR)
Change
12.8 11.43 8.14 11.35 6.65 29.32
All amounts in millions
from last financial year
         
Implied Share Price $96.46 $46.59 $83.01 $93.21 $21.29
Market Cap 242,575 208,540 196,987 144,186 129,595
Net Debt -4,924 4,752 11,607 4,428 14,037
Enterprise Value (EV) 237,651 213,292 191,278 148,614 271,643
Revenue 67,224 58,986 57,561 47,267 26,431
EBITDA 20,791 26,199 16,848 22,343 9,266
Percent 30.9 % 44.4 % 29.3 % 47.3 % 35.1 %
EBIT 17,145 19,171 12,250 15,600 7,821
Percent 25.5 % 32.5 % 21.3 % 33.0 % 29.6 %
Balance Sheet          
Total Assets 121,347 185,798 124,216 106,132 41,475
Total Liabilities 56,521 104,538 55,123 53,112 35,665
Shareholders Equity 64,826 81,260 69,093 53,020 5,810.0

Price history

Comments

No comments yet. Login to comment.